Integrated Investment Consultants, LLC Astrazeneca PLC Transaction History

Integrated Investment Consultants, LLC

$4.71 Billion
Q4 2024

A detailed history of Integrated Investment Consultants, LLC transactions in Astrazeneca PLC stock. As of the latest transaction made, Integrated Investment Consultants, LLC holds 4,034 shares of AZN stock, worth $268,664. This represents 0.01% of its overall portfolio holdings.

Number of Shares

4,034

Previous 4,318 6.58%

Holding current value

$268,664

Previous $336,000 21.43%

% of portfolio

0.01%

Previous 0.01%

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Jan 15, 2025	SELL	$63.2 - $79.58 $17,948 - $22,600	-284 Reduced 6.58%	4,034 $264,000
Q3 2024 Nov 12, 2024	BUY	$76.67 - $87.62 $331,061 - $378,343	4,318 New	4,318 $336,000
Q1 2023 Jul 18, 2023	BUY	$63.15 - $71.6 $559,256 - $634,089	8,856 New	8,856 $614,000
Q4 2022 Feb 13, 2023	BUY	$54.21 - $70.44 $7,968 - $10,354	147 Added 1.48%	10,073 $682,000
Q3 2022 Nov 21, 2022	SELL	$53.02 - $135.75 $13,785 - $35,295	-260 Reduced 2.55%	9,926 $545,000
Q2 2022 Jul 19, 2022	SELL	$59.26 - $71.14 $273,781 - $328,666	-4,620 Reduced 31.2%	10,186 $672,000
Q1 2022 May 16, 2022	SELL	$55.72 - $67.12 $107,428 - $129,407	-1,928 Reduced 11.52%	14,806 $982,000
Q3 2021 Oct 28, 2021	BUY	$55.56 - $60.79 $13,890 - $15,197	250 Added 1.52%	16,734 $1.01 Million
Q2 2021 Jul 21, 2021	BUY	$48.42 - $60.18 $341,845 - $424,870	7,060 Added 74.92%	16,484 $988,000
Q1 2021 Apr 20, 2021	SELL	$47.16 - $54.44 $52,819 - $60,972	-1,120 Reduced 10.62%	9,424 $468,000
Q4 2020 Feb 09, 2021	BUY	$48.52 - $58.02 $43,668 - $52,218	900 Added 9.33%	10,544 $527,000
Q3 2020 Oct 26, 2020	BUY	$53.07 - $61.1 $52,380 - $60,305	987 Added 11.4%	9,644 $528,000
Q2 2020 Aug 04, 2020	SELL	$43.1 - $55.31 $68,098 - $87,389	-1,580 Reduced 15.43%	8,657 $458,000
Q1 2020 May 22, 2020	BUY	$37.79 - $51.33 $79,018 - $107,331	2,091 Added 25.67%	10,237 $457,000
Q4 2019 Jan 29, 2020	BUY	$42.46 - $50.46 $63,392 - $75,336	1,493 Added 22.44%	8,146 $406,000
Q3 2019 Oct 21, 2019	BUY	$40.12 - $45.47 $248,463 - $281,595	6,193 Added 1346.3%	6,653 $296,000
Q2 2018 Aug 01, 2018	BUY	$34.55 - $37.05 $1,934 - $2,074	56 Added 13.86%	460 $16,000
Q1 2018 Apr 12, 2018	BUY	$32.97 - $36.63 $13,319 - $14,798	404 New	404 $14,000

Others Institutions Holding AZN

# of Institutions

1,349

Shares Held

475M

Call Options Held

5.39M

Put Options Held

3.75M

View Full List

About ASTRAZENECA PLC

Ticker AZN
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 3,099,020,032
Market Cap $206B
Description
AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...

More about AZN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Integrated Investment Consultants, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Integrated Investment Consultants, LLC with notifications on news.

Account

Integrated Investment Consultants, LLC Astrazeneca PLC Transaction History